Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Erythropoietin Drugs Market Size study, By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), By Application (Cancer, Hematology, Neurology & Renal Diseases) & Regional Forecasts 2021-2027

Published by Bizwit Research & Consulting LLP Product code 1009685
Published Content info
Delivery time: 2-3 business days
Price
Back to Top
Global Erythropoietin Drugs Market Size study, By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), By Application (Cancer, Hematology, Neurology & Renal Diseases) & Regional Forecasts 2021-2027
Published: June 5, 2021 Content info:
Description

Global Erythropoietin Drugs Market is valued approximately USD 11.05 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 11.30% over the forecast period 2021-2027. Erythropoietin is a hormone produced by the kidney that encourages the formation of red blood cells by the bone marrow. The subsequent rise in red cells increases the oxygen-carrying capacity of the blood. Erythropoietin drugs are used as a medication to treat anemia (low red blood cell count) in patients with long-term serious kidney disease (chronic kidney failure), people receiving zidovudine to treat HIV, and people receiving chemotherapy for some types of cancer. The rise in the cases of chronic kidney diseases as well as in the patients of HIV and anemia are increasing the demand for erythropoietin drugs.

According to National Kidney Foundation in 2018, kidney disease affects an estimated 37 million people in the U.S.A. In 2018, 785,883 Americans had kidney failure, and needed dialysis or a kidney transplant to survive. Also, 12 people die every day while waiting for a kidney transplant. Centre for Disease Control reports that more than 1 in 7, that is 15% of US adults or 37 million people, are estimated to have Chronic Kidney Disease (CKD). Diabetes and high blood pressure are the usual causes of CKD in adults. Other risk factors include heart disease, obesity, a family history of disease and older age. The rising diabetic and heart patients too are causing the increased demand for erythropoietin drugs. The high cost of manufacturing erythropoietin drugs, particularly in developing countries, may act as a restraint for its growth. However, as the patents of major companies are expiring in the near future, the market for generic biologics and biosimilars is ripe to capture. This acts as an opportunity for Erythropoietin Drugs Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Erythropoietin Drugs Market. Due to higher number of patients of chronic kidney diseases as well as higher per capita income and hence more expenditure on health, North America is a significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 owing to the increasing cases of anemia and HIV in developing countries. Rising disposable income and government as well as private investment in healthcare sector will also boost growth in this region.

Major market player included in this report are:

Johnson & Johnson

Celltrion, Inc.

Teva Pharmaceutical Industries Ltd

Amgen, Inc.

Hoffman-La Roche Ltd.

LG Life Sciences Ltd.

Biocon Limited

Intas Pharmaceuticals Ltd.

Sun Pharmaceutical Industries Ltd.

Dr. Reddy's Laboratories Ltd.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Biologics

Biosimilars

By Product:

Epoetin-alfa

Epoetin-beta

Darbepoetin-alfa

Others

By Application:

Cancer

Hematology

Renal Diseases

Neurology

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027

Target Audience of the Global Erythropoietin Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Table of Contents

Chapter 1.Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Erythropoietin Drugs Market, by Drug Class, 2019-2027 (USD Billion)
    • 1.2.2. Erythropoietin Drugs Market, by Product, 2019-2027 (USD Billion)
    • 1.2.3. Erythropoietin Drugs Market, by Application, 2019-2027 (USD Billion)
    • 1.2.4. Erythropoietin Drugs Market, by, 2019-2027 (USD Billion)
    • 1.2.5. Erythropoietin Drugs Market, by, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Erythropoietin Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Erythropoietin Drugs Market Dynamics

  • 3.1. Erythropoietin Drugs Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing demand from patients of HIV and kidney Diseases
      • 3.1.1.2. Rising incidence of diabetes and heart diseases
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of production of drugs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Patent expiration of major drug manufacturers

Chapter 4. Global Erythropoietin Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Erythropoietin Drugs Market, by Drug Class

  • 5.1. Market Snapshot
  • 5.2. Global Erythropoietin Drugs Market by Drug Class, Performance - Potential Analysis
  • 5.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)
  • 5.4. Erythropoietin Drugs Market, Sub Segment Analysis
    • 5.4.1. Biologics
    • 5.4.2. Biosimilars

Chapter 6. Global Erythropoietin Drugs Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Erythropoietin Drugs Market by Product, Performance - Potential Analysis
  • 6.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
  • 6.4. Erythropoietin Drugs Market, Sub Segment Analysis
    • 6.4.1. Epoetin-alfa
    • 6.4.2. Epoetin-beta
    • 6.4.3. Darbepoetin-alfa
    • 6.4.4. Others

Chapter 7. Global Erythropoietin Drugs Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Erythropoietin Drugs Market by Application, Performance - Potential Analysis
  • 7.3. Global Erythropoietin Drugs Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
  • 7.4. Erythropoietin Drugs Market, Sub Segment Analysis
    • 7.4.1. Cancer
    • 7.4.2. Haematology
    • 7.4.3. Renal Diseases
    • 7.4.4. Neurology

Chapter 8. Global Erythropoietin Drugs Market, Regional Analysis

  • 8.1. Erythropoietin Drugs Market, Regional Market Snapshot
  • 8.2. North America Erythropoietin Drugs Market
    • 8.2.1. U.S. Erythropoietin Drugs Market
      • 8.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2027
      • 8.2.1.2. Product breakdown estimates & forecasts, 2018-2027
      • 8.2.1.3. Application breakdown estimates & forecasts, 2018-2027
    • 8.2.2. Canada Erythropoietin Drugs Market
  • 8.3. Europe Erythropoietin Drugs Market Snapshot
    • 8.3.1. U.K. Erythropoietin Drugs Market
    • 8.3.2. Germany Erythropoietin Drugs Market
    • 8.3.3. France Erythropoietin Drugs Market
    • 8.3.4. Spain Erythropoietin Drugs Market
    • 8.3.5. Italy Erythropoietin Drugs Market
    • 8.3.6. Rest of Europe Erythropoietin Drugs Market
  • 8.4. Asia-Pacific Erythropoietin Drugs Market Snapshot
    • 8.4.1. China Erythropoietin Drugs Market
    • 8.4.2. India Erythropoietin Drugs Market
    • 8.4.3. Japan Erythropoietin Drugs Market
    • 8.4.4. Australia Erythropoietin Drugs Market
    • 8.4.5. South Korea Erythropoietin Drugs Market
    • 8.4.6. Rest of Asia Pacific Erythropoietin Drugs Market
  • 8.5. Latin America Erythropoietin Drugs Market Snapshot
    • 8.5.1. Brazil Erythropoietin Drugs Market
    • 8.5.2. Mexico Erythropoietin Drugs Market
  • 8.6. Rest of The World Erythropoietin Drugs Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Johnson & Johnson
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Celltrion, Inc.
    • 9.2.3. Teva Pharmaceutical Industries Ltd
    • 9.2.4. Amgen, Inc.
    • 9.2.5. Hoffman-La Roche Ltd.
    • 9.2.6. LG Life Sciences Ltd.
    • 9.2.7. Biocon Limited
    • 9.2.8. Intas Pharmaceuticals Ltd.
    • 9.2.9. Sun Pharmaceutical Industries Ltd.
    • 9.2.10. Dr. Reddy's Laboratories Ltd.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Erythropoietin Drugs Market, report scope
  • TABLE 2. Global Erythropoietin Drugs Market estimates & forecasts by Region 2018-2027 (USD Billion)
  • TABLE 3. Global Erythropoietin Drugs Market estimates & forecasts by Drug Class 2018-2027 (USD Billion)
  • TABLE 4. Global Erythropoietin Drugs Market estimates & forecasts by Product 2018-2027 (USD Billion)
  • TABLE 5. Global Erythropoietin Drugs Market estimates & forecasts by Application 2018-2027 (USD Billion)
  • TABLE 6. Global Erythropoietin Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 7. Global Erythropoietin Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Erythropoietin Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Erythropoietin Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Erythropoietin Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Erythropoietin Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Erythropoietin Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Erythropoietin Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Erythropoietin Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. Global Erythropoietin Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. U.S. Erythropoietin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 17. U.S. Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 18. U.S. Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 19. Canada Erythropoietin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 20. Canada Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 21. Canada Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 22. UK Erythropoietin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 23. UK Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 24. UK Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 25. Germany Erythropoietin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 26. Germany Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 27. Germany Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 28. RoE Erythropoietin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 29. RoE Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 30. RoE Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 31. China Erythropoietin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 32. China Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 33. China Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 34. India Erythropoietin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 35. India Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 36. India Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 37. Japan Erythropoietin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 38. Japan Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 39. Japan Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 40. RoAPAC Erythropoietin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 41. RoAPAC Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 42. RoAPAC Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 43. Brazil Erythropoietin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 44. Brazil Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 45. Brazil Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 46. Mexico Erythropoietin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 47. Mexico Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 48. Mexico Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 49. RoLA Erythropoietin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 50. RoLA Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 51. RoLA Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 52. Row Erythropoietin Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 53. Row Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 54. Row Erythropoietin Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of global Erythropoietin Drugs Market
  • TABLE 56. List of primary sources, used in the study of global Erythropoietin Drugs Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Erythropoietin Drugs Market, research methodology
  • FIG 2. Global Erythropoietin Drugs Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Erythropoietin Drugs Market, key trends 2020
  • FIG 5. Global Erythropoietin Drugs Market, growth prospects 2021-2027
  • FIG 6. Global Erythropoietin Drugs Market, porters 5 force model
  • FIG 7. Global Erythropoietin Drugs Market, pest analysis
  • FIG 8. Global Erythropoietin Drugs Market, value chain analysis
  • FIG 9. Global Erythropoietin Drugs Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Erythropoietin Drugs Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Erythropoietin Drugs Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Erythropoietin Drugs Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Erythropoietin Drugs Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Erythropoietin Drugs Market, regional snapshot 2018 & 2027
  • FIG 15. North America Erythropoietin Drugs Market 2018 & 2027 (USD Billion)
  • FIG 16. Europe Erythropoietin Drugs Market 2018 & 2027 (USD Billion)
  • FIG 17. Asia pacific Erythropoietin Drugs Market 2018 & 2027 (USD Billion)
  • FIG 18. Latin America Erythropoietin Drugs Market 2018 & 2027 (USD Billion)
  • FIG 19. Global Erythropoietin Drugs Market, company market share analysis (2020)
Back to Top